Inmunomet Intolerancia y Disbiosis

Inmunomet Intolerancia y Disbiosis is a multidisciplinary medical service dedicated to assisting patients with food malabsorption and intestinal dysbiosis. Founded in 2018, it is the first of its kind, utilizing tested protocols and evidence-based medicine principles along with its own research and study lines. The service integrates various units including Medical-Surgical Digestive (endoscopies and functional tests), Clinical Laboratory, Diagnostic Imaging, Rheumatology, Pulmonology, and Otolaryngology. Its method for addressing these conditions is based on the sequence: diagnosis, supplementation, diet, and food reintroduction.

Operating in the Health Care industry, Inmunomet's unique approach and comprehensive services cater to the unmet needs of patients with food malabsorption and dysbiosis. Although details regarding their headquarters, last investment, and investors are not specified, the company's focus on a burgeoning area of healthcare presents a compelling investment opportunity, particularly given the increasing awareness and focus on digestive health and related conditions.